Tirzepatide is a dual GIP and GLP-1 receptor agonist that affects satiety, insulin response, and glucose control. It is commonly studied for appetite reduction, metabolic regulation, and weight-management pathways.
Tried Retatrutide after reading about the triple-agonist mechanism. Interesting compound. Results in our lab have been consistent so far.

